AgeX Therapeutics Balance Sheet Health
Financial Health criteria checks 1/6
AgeX Therapeutics has a total shareholder equity of $5.4M and total debt of $4.4M, which brings its debt-to-equity ratio to 81.5%. Its total assets and total liabilities are $12.0M and $6.6M respectively.
Key information
81.5%
Debt to equity ratio
US$4.37m
Debt
| Interest coverage ratio | n/a |
| Cash | US$345.00k |
| Equity | US$5.36m |
| Total liabilities | US$6.61m |
| Total assets | US$11.97m |
Financial Position Analysis
Short Term Liabilities: AGE's short term assets ($754.0K) do not cover its short term liabilities ($5.9M).
Long Term Liabilities: AGE's short term assets ($754.0K) exceed its long term liabilities ($693.0K).
Debt to Equity History and Analysis
Debt Level: AGE's net debt to equity ratio (75%) is considered high.
Reducing Debt: AGE's debt to equity ratio has increased from 0% to 81.5% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: AGE has less than a year of cash runway based on its current free cash flow.
Forecast Cash Runway: AGE has less than a year of cash runway if free cash flow continues to grow at historical rates of 5.6% each year.